Page last updated: 2024-12-08

n-acetylmethionine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-acetylmethionine: RN given refers to L-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-acetylmethionine : A methionine derivative that is methionine in which one of the amine hydrogens is substituted by an acetyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID448580
CHEBI ID21557
SCHEMBL ID109681
MeSH IDM0048891

Synonyms (70)

Synonym
n-acetyl(methyl)homocysteine
DIVK1C_001361
nsc 118514
brn 1725552
ccris 5537
einecs 200-617-7
methionine, n-acetyl-, l-
CDS1_000321
thiomedon
l-(n-acetyl)methionine
methionamine
nsc-118514
acetylmethionine
acetyl-l-methionine
n-acetyl-l-methionine ,
l-methionine, n-acetyl-
65-82-7
methionin
acetylmethionin
n-acetylmethionine
C02712
SR-01000634087-1
(2s)-2-acetamido-4-(methylsulfanyl)butanoic acid
acmet
DB01646
n-ac-met
nalpha-acetyl-l-methionine
MAYBRIDGE1_002609
E3863D59-A4FA-4911-8B98-90D79E986E03
ac-met-oh
AKOS000302150
(2s)-2-acetamido-4-methylsulfanylbutanoic acid
HMS548O13
4-04-00-03205 (beilstein handbook reference)
9j12wx5b6a ,
unii-9j12wx5b6a
(s)-2-acetylamino-4-methylsulfanyl-butyric acid
CHEBI:21557
CCG-44238
AM20100588
S6205
follicusan
n-acetyl-l-2-amino-4-(methylthio)butyric acid
acetyl methionine
n-acetylmethionine [mi]
acetylmethionine [who-dd]
methionine, n-acetyl-, l
n-acetyl-l-methionine [fcc]
acetyl methionine [inci]
SCHEMBL109681
(s)-2-acetamido-4-(methylthio)butanoic acid
n-acetyl methionine
n-acetyl(methyl)homocysteine #
Q-201442
J-300194
l-n-acetylmethionine
n-acetyl-methionine
mfcd00064441
n-acetyl-l-methionine, >=98.5% (t)
(2s)-2-(acetylamino)-4-(methylsulfanyl)butanoic acid (n-acetyl-l-methionine)
CS-W013215
l-n-acetyl-methionine
n-acetyl-s-methylhomocysteine
n-acetyl-l-met
Q27092828
AS-12697
HY-W012499
DTXSID00883214
EN300-119385
Z756444180

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The obtained results confirmed the influence of ILs' structural elements on its toxicity and revealed that pyridinium and phosphonium cations, longer alkyl side chains and tetrafluoroborate anion displayed higher toxic effect on enzyme activity."( Assessment of ionic liquids' toxicity through the inhibition of acylase I activity on a microflow system.
Araujo, ARTS; Azevedo, AMO; Costa, SPF; Passos, MLC; Pereira, SAP; Pinto, PCAG; Saraiva, MLMFS, 2017
)
0.46

Dosage Studied

ExcerptRelevanceReference
" In group P a statistically significant, but transitory, rise in plasma ALAT level following dosage was seen."( Efficacy of paracetamol-esterified methionine versus cysteine or methionine on paracetamol-induced hepatic GSH depletion and plasma ALAT level in mice.
Aalen, O; Ingebrigtsen, K; Nafstad, I; Skoglund, LA, 1986
)
0.27
" There was no observed cellular damage of the liver or kidneys assessed histologically or by plasma ALAT after dosing with a racemic mixture of N-acetyl-DL-methionine."( Effects of N-acetyl-DL-methionine on the liver, GSH synthesis and plasma ALAT level in male Bom:NMRI mice.
Ingebrigtsen, K; Nafstad, I; Skoglund, LA, 1986
)
0.27
" Rumen NALM dosing led to a linear increase in plasma Met concentration."( Plasma methionine appearance and residual potential of supplemented N-acetyl-L-methionine through ruminal or abomasal infusion in dairy cows.
Eun, JS; Fagundes, MA; Hall, JO,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
nutraceuticalA product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
N-acetyl-L-amino acidAn L-amino acid having an N-acetyl substituent.
L-methionine derivativeA proteinogenic amino acid derivative resulting from reaction of L-methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-methionine by a heteroatom.
N-acetylmethionineA methionine derivative that is methionine in which one of the amine hydrogens is substituted by an acetyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (73)

TimeframeStudies, This Drug (%)All Drugs %
pre-199031 (42.47)18.7374
1990's10 (13.70)18.2507
2000's13 (17.81)29.6817
2010's16 (21.92)24.3611
2020's3 (4.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.38 (24.57)
Research Supply Index4.41 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index54.66 (26.88)
Search Engine Supply Index2.06 (0.95)

This Compound (38.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (5.19%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other73 (94.81%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]